|
Market Closed -
Nasdaq
04:00:00 2026-07-14 pm EDT
|
5-day change | 1st Jan Change | ||
| 31.49 USD | +0.03% |
|
-.--% | +34.92% |
| Aug. 03 | CDP targets new defense acquisitions after T-Defence deal - sources | RE |
| Aug. 03 | CDP's new chapter, a push for global companies | AN |
| Market Cap | 3.85B 3.3B 3.1B 2.83B 5.34B 368B 5.39B 36.51B 14.21B 185B 14.47B 14.16B 614B | P/E 2024 |
15.9x | P/E 2025 | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 3.15B 2.7B 2.53B 2.31B 4.36B 300B 4.4B 29.82B 11.61B 151B 11.82B 11.56B 502B | EV / Sales 2024 |
4.02x | EV / Sales 2025 | 3.67x |
| Free-Float |
99.94% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Catalyst Pharmaceuticals, Inc.
| 1 day | +0.03% | ||
| 3 months | +0.74% | ||
| 6 months | +26.67% | ||
| Current year | +34.92% |
| Current year | 22.13 |  | 32.56 |
| 1 year | 19.05 | | 32.56 |
| 3 years | 11.55 | | 32.56 |
| 5 years | 4.81 | | 32.56 |
| 10 years | 0.94 | | 32.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Daly
CEO | Chief Executive Officer | 65 | 2023-12-31 |
Michael Kalb
DFI | Director of Finance/CFO | 55 | 2023-12-31 |
William Andrews
CTO | Chief Tech/Sci/R&D Officer | 62 | 2025-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 48 | 2026-07-14 | |
Massimo Marin
BRD | Director/Board Member | - | 2026-07-14 |
Enrica Dogali
BRD | Director/Board Member | - | 2026-07-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/15/26 | Issuer sale | Director | -63,583 | 0.0519% | ||
| 7/15/26 | Issuer sale | Director | -130,857 | 0.1069% | ||
| 7/15/26 | Issuer sale | Executive/Senior Manager | -1,051,183 | 0.8587% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | -.--% | +52.72% | +121.14% | 3.85B | |
| +0.61% | +2.88% | +45.63% | +0.39% | 82.73B | |
| +0.09% | +4.36% | -19.25% | -35.16% | 57.94B | |
| +14.36% | +152.27% | +526.55% | +41.90% | 55.45B | |
| +0.76% | +3.53% | +0.08% | +36.18% | 52.57B | |
| +1.86% | +3.13% | +11.49% | +174.36% | 48.94B | |
| +1.21% | +3.87% | +61.90% | -16.51% | 32.23B | |
| +1.36% | +5.06% | +53.04% | +103.13% | 25.94B | |
| +8.39% | +10.43% | +13.32% | +212.23% | 22.1B | |
| +3.89% | +1.08% | +61.82% | +112.10% | 16.55B | |
| Average | +3.25% | +19.90% | +80.73% | +74.98% | 39.83B | |
| Weighted average by Cap. | +3.28% | +27.13% | +93.68% | +49.99% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 492M 421M 395M 361M 681M 46.88B 687M 4.66B 1.81B 23.65B 1.85B 1.81B 78.33B | 589M 505M 473M 432M 815M 56.15B 823M 5.58B 2.17B 28.33B 2.21B 2.16B 93.82B |
| Net income | 164M 140M 132M 120M 227M 15.62B 229M 1.55B 604M 7.88B 615M 602M 26.11B | 214M 184M 172M 157M 297M 20.43B 300M 2.03B 790M 10.31B 805M 787M 34.14B |
| Net Debt | -514M -441M -413M -377M -712M -49.04B -719M -4.87B -1.9B -24.74B -1.93B -1.89B -81.93B | -706M -605M -567M -518M -978M -67.34B -987M -6.69B -2.6B -33.98B -2.65B -2.59B -113B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CPRX Stock
Select your edition
All financial news and data tailored to specific country editions
